Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to 0.09%.

  • Haemonetics' Return on Invested Capital rose 200.0% to 0.09% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.09%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.1% for FY2025, which is 100.0% up from last year.
  • Haemonetics' Return on Invested Capital amounted to 0.09% in Q4 2025, which was up 200.0% from 0.09% recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Return on Invested Capital registered a high of 0.11% during Q3 2023, and its lowest value of 0.04% during Q1 2022.
  • Its 5-year average for Return on Invested Capital is 0.08%, with a median of 0.09% in 2025.
  • Per our database at Business Quant, Haemonetics' Return on Invested Capital tumbled by -800bps in 2022 and then skyrocketed by 500bps in 2023.
  • Over the past 5 years, Haemonetics' Return on Invested Capital (Quarter) stood at 0.05% in 2021, then surged by 63bps to 0.09% in 2022, then increased by 9bps to 0.09% in 2023, then decreased by -20bps to 0.08% in 2024, then rose by 21bps to 0.09% in 2025.
  • Its Return on Invested Capital was 0.09% in Q4 2025, compared to 0.09% in Q3 2025 and 0.09% in Q2 2025.